- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
166 Blätter
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Albert-Ludwigs-University Freiburg, Germany, Dissertation, 2019
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:13 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- April 2019
Ähnliche Objekte (12)
"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom
Developing targeted therapies for pediatric PFA ependymoma
Prostate cancer stem cells: Clinical aspects and targeted therapies
Targeted therapies for the treatment of triple-negative breast cancer
Network meta-analysis for the integrated evaluation of targeted therapies
Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis
Molecular mechanisms of PI3K/mTOR-targeted therapies in hepatocellular carcinoma
Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies
Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges
Drug screening to identify targeted therapies in atypical teratoid/rhabdoid tumors
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician
"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom
Developing targeted therapies for pediatric PFA ependymoma
Prostate cancer stem cells: Clinical aspects and targeted therapies
Targeted therapies for the treatment of triple-negative breast cancer
Network meta-analysis for the integrated evaluation of targeted therapies
Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis
Molecular mechanisms of PI3K/mTOR-targeted therapies in hepatocellular carcinoma
Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies
Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges
Drug screening to identify targeted therapies in atypical teratoid/rhabdoid tumors
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician
"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom
Developing targeted therapies for pediatric PFA ependymoma
Prostate cancer stem cells: Clinical aspects and targeted therapies
Targeted therapies for the treatment of triple-negative breast cancer
Network meta-analysis for the integrated evaluation of targeted therapies
Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis
Molecular mechanisms of PI3K/mTOR-targeted therapies in hepatocellular carcinoma
Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies
Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges
Drug screening to identify targeted therapies in atypical teratoid/rhabdoid tumors
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma